Page last updated: 2024-10-29

iodixanol and Esophageal Atresia

iodixanol has been researched along with Esophageal Atresia in 1 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Esophageal Atresia: Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nakagawa, Y1
Uchida, H1
Shirota, C1
Tainaka, T1
Sumida, W1
Makita, S1
Amano, H1
Takimoto, A1
Ogata, S1
Takada, S1
Maeda, T1
Gohda, Y1
Guo, Y1
Hinoki, A1

Other Studies

1 other study available for iodixanol and Esophageal Atresia

ArticleYear
Preoperative Contrast Examinations Help Determine the Appropriate Cervical Approach for Congenital Gross Type C Esophageal Atresia: A Report of Two Cases.
    The American journal of case reports, 2023, Jun-13, Volume: 24

    Topics: Esophageal Atresia; Humans; Male; Triiodobenzoic Acids

2023